Prognostic scores for colorectal liver metastasis: Clinically important or an academic exercise?

HPB

Volumn 12, Issue 4, 2010, Pages 227-238

  Gomez, Dhanwant ^a   Cameron, Iain C ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Colorectal cancer; Hepatectomy; Hepatic resection; Liver metastases

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CARCINOEMBRYONIC ANTIGEN;

ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL PRACTICE; COLORECTAL CANCER; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER RESECTION; MEDLINE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; COLORECTAL TUMOR; HEALTH STATUS INDICATOR; LIVER NEOPLASMS; MORTALITY; PATHOLOGY; PATIENT SELECTION; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; SECONDARY; SURVIVAL; TIME; TREATMENT OUTCOME;

CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; HEALTH STATUS INDICATORS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; NEOADJUVANT THERAPY; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77953576166     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2010.00158.x     Document Type: Review

References (57)

1. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM. (2004) Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240:438-447; discussion 447-450.
2. Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M et al. (2007) Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25:4575-4580.
3. Gomez D, Morris-Stiff G, Wyatt J, Toogood GJ, Lodge JP, Prasad KR. (2008) Surgical technique and systemic inflammation influences longterm disease-free survival following hepatic resection for colorectal metastasis. J Surg Oncol 98:371-376.
4. Memon MA, Beckingham IJ. (2001) Surgical resection of colorectal liver metastases. Colorectal Dis 3:361-373.
5. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P et al. (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial. Lancet 355:1041-1047.
6. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ et al. (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343:905-914.
7. De Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J et al. (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938-2947.
8. Ekberg H, Tranberg KG, Andersson R, Lundstedt C, Hagerstrand I, Ranstam J et al. (1986) Determinants of survival in liver resection for colorectal secondaries. Br J Surg 73:727-731.
9. Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K et al. (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138:1198-1206.
10. Heriot AG, Karanjia ND. (2002) A review of techniques for liver resection. Ann R Coll Surg Engl 84:371-380.
11. Jaeck D, Bachellier P, Nakano H, Oussoultzoglou E, Weber JC, Wolf P et al. (2003) One or two-stage hepatectomy combined with portal vein embolization for initially non-resectable colorectal liver metastases. Am J Surg 185:221-229.
12. Garden OJ, Rees M, Poston GJ, Mirza D, Saunders M, Ledermann J et al. (2006) Guidelines for resection of colorectal cancer liver metastases. Gut 55 (Suppl. 3):1-8.
13. Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D et al. (2001) Five-year survival following hepatic resection after neoadjuvant therapy for non-resectable colorectal [liver] metastases. Ann Surg Oncol 8:347-353.
14. Muratore A, Polastri R, Bouzari H, Vergara V, Ferrero A, Capussotti L. (2001) Repeat hepatectomy for colorectal liver metastases: a worthwhile operation? J Surg Oncol 76:127-132.
15. Suzuki S, Sakaguchi T, Yokoi Y, Kurachi K, Okamoto K, Okumura T et al. (2001) Impact of repeat hepatectomy on recurrent colorectal liver metastases. Surgery 129:421-428.
16. Yamada H, Katoh H, Kondo S, Okushiba S, Morikawa T. (2001) Repeat hepatectomy for recurrent hepatic metastases from colorectal cancer. Hepatogastroenterology 48:828-830.
17. Nishio H, Hamady ZZ, Malik HZ, Fenwick S, Rajendra Prasad K, Toogood GJ et al. (2007) Outcome following repeat liver resection for colorectal liver metastases. Eur J Surg Oncol 33:729-734.
18. Kanemitsu Y, Kato T, Hirai T, Yasui K. (2004) Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer. Br J Surg 91:112-120.
19. Vogelsang H, Haas S, Hierholzer C, Berger U, Siewert JR, Prauer H. (2004) Factors influencing survival after resection of pulmonary metastases from colorectal cancer. Br J Surg 91:1066-1071.
20. Wong VK, Malik HZ, Hamady ZZ, Al-Mukhtar A, Gomez D, Prasad KR et al. (2007) C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases. Br J Cancer 96:222-225.
21. Are C, Gonen M, Zazzali K, Dematteo RP, Jarnagin WR, Fong Y et al. (2007) The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg 246:295-300.
22. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD et al. (2002) Trends in longterm survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759-766.
23. Elias D, Ouellet JF, Bellon N, Pignon JP, Pocard M, Lasser P. (2003) Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 90:567-574.
24. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P et al. (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française De Chirurgie. Cancer 77:1254-1262.
25. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309-318.
26. Iwatsuki S, Dvorchik I, Madariaga JR, Marsh JW, Dodson F, Bonham AC et al. (1999) Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 189:291-299.
27. Ueno H, Mochizuki H, Hatsuse K, Hase K, Yamamoto T. (2000) Indicators for treatment strategies of colorectal liver metastases. Ann Surg 231:59-66.
28. Lise M, Bacchetti S, Da Pian P, Nitti D, Pilati P. (2001) Patterns of recurrence after resection of colorectal liver metastases: prediction by models of outcome analysis. World J Surg 25:638-644.
29. Nagashima I, Takada T, Matsuda K, Adachi M, Nagawa H, Muto T et al. (2004) A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection. J Hepatobiliary Pancreat Surg 11:79-83.
30. Schindl M, Wigmore SJ, Currie EJ, Laengle F, Garden OJ. (2005) Prognostic scoring in colorectal cancer liver metastases: development and validation. Arch Surg 140:183-189.
31. Malik HZ, Prasad KR, Halazun KJ, Aldoori A, Al-Mukhtar A, Gomez D et al. (2007) Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg 246:806-814.
32. Zakaria S, Donohue JH, Que FG, Farnell MB, Schleck CD, Ilstrup DM et al. (2007) Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg 246:183-191.
33. Lee WS, Kim MJ, Yun SH, Chun HK, Lee WY, Kim SJ et al. (2008) Risk factor stratification after simultaneous liver and colorectal resection for synchronous colorectal metastasis. Langenbecks Arch Surg 393:13-19.
34. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. (2008) Evaluation of longterm survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247:125-135.
35. Konopke R, Kersting S, Distler M, Dietrich J, Gastmeier J, Heller A et al. (2009) Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases. Liver Int 29:89-102.
36. Meric F, Patt YZ, Curley SA, Chase J, Roh MS, Vauthey JN et al. (2000) Surgery after downstaging of unresectable hepatic tumours with intraarterial chemotherapy. Ann Surg Oncol 7:490-495.
37. Bodingbauer M, Tamandl D, Schmid K, Plank C, Schima W, Gruenberger T. (2007) Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg 94:1133-1138.
38. Figueras J, Burdio F, Ramos E, Torras J, Llado L, Lopez-Ben S et al. (2007) Effect of subcentimetre non-positive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections. Ann Oncol 18:1190-1195.
39. Hamady ZZ, Cameron IC, Wyatt J, Prasad RK, Toogood GJ, Lodge JP. (2006) Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1-cm rule. Eur J Surg Oncol 32:557-563.
40. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P et al. (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomized controlled trial. Lancet 371:1007-1016.
41. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM et al. (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065-2072.
42. Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM. (2005) Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 200:845-853.
43. Justice AC, Covinsky KE, Berlin JA. (1999) Assessing the generalizability of prognostic information. Ann Intern Med 130:515-524.
44. Mann CD, Metcalfe MS, Leopardi LN, Maddern GJ. (2004) The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. Arch Surg 139:1168-1172.
45. Mala T, Bohler G, Mathisen O, Bergan A, SoreiDe O. (2002) Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg 26:1348-1353.
46. Merkel S, Bialecki D, Meyer T, Muller V, Papadopoulos T, Hohenberger W. (2009) Comparison of clinical risk scores predicting prognosis after resection of colorectal liver metastases. J Surg Oncol 100:349-357.
47. Malik HZ, Farid S, Al-Mukthar A, Anthoney A, Toogood GJ, Lodge JP et al. (2007) A critical appraisal of the role of neoadjuvant chemotherapy for colorectal liver metastases: a case-controlled study. Ann Surg Oncol 14:3519-3526.
48. Mehta NN, Ravikumar R, Coldham CA, Buckels JA, Hubscher SG, Bramhall SR et al. (2008) Effect of preoperative chemotherapy on liver resection for colorectal liver metastases. Eur J Surg Oncol 34:782-786.
49. Fong Y, Blumgart LH, Cohen A, Fortner J, Brennan MF. (1994) Repeat hepatic resections for metastatic colorectal cancer. Ann Surg 220:657-662.
50. Pinson CW, Wright JK, Chapman WC, Garrard CL, Blair TK, Sawyers JL. (1996) Repeat hepatic surgery for colorectal cancer metastasis to the liver. Ann Surg 223:765-773.
51. Beard SM, Holmes M, Price C, Majeed AW. (2000) Hepatic resection for colorectal liver metastases: a cost-effectiveness analysis. Ann Surg 232:763-776.
52. Gazelle GS, Hunink MG, Kuntz KM, McMahon PM, Halpern EF, Beinfeld M et al. (2003) Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis. Ann Surg 237:544-555.
53. Bhattacharjya S, Aggarwal R, Davidson BR. (2006) Intensive follow-up after liver resection for colorectal liver metastases: results of combined serial tumour marker estimations and computed tomography of the chest and abdomen - a prospective study. Br J Cancer 95:21-26.
54. Metcalfe M, Mann C, Mullin E, Maddern G. (2005) Detecting curable disease following hepatectomy for colorectal metastases. Aust N Z J Surg 75:524-527.
55. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. (1995) Resection of colorectal liver metastases. World J Surg 19:59-71.
56. Valk PE, Abella-Columna E, Haseman MK, Pounds TR, Tesar RD, Myers RW et al. (1999) Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg 134:503-511.
57. Flanagan FL, Dehdashti F, Ogunbiyi OA, Kodner IJ, Siegel BA. (1998) Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 227:319-323.